Literature DB >> 26337039

Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update.

Kathleen T Brady1, Jenna L McCauley1, Sudie E Back1.   

Abstract

OBJECTIVE: Prescription opioid abuse and dependence have escalated rapidly in the United States over the past 20 years, leading to high rates of overdose deaths and a dramatic increase in the number of people seeking treatment for opioid dependence. The authors review the scope of the abuse and overdose epidemic, prescription practices, and the assessment, treatment, and prevention of prescription opioid misuse and dependence.
METHOD: The authors provide an overview of the literature from 2006 to the present, with the twin goals of highlighting advances in prevention and treatment and identifying remaining gaps in the science.
RESULTS: A number of policy and educational initiatives at the state and federal government level have been undertaken in the past 5 years to help providers and consumers, respectively, prescribe and use opioids more responsibly. Initial reports suggest that diversion and abuse levels have begun to plateau, likely as a result of these initiatives. While there is a large body of research suggesting that opioid substitution coupled with psychosocial interventions is the best treatment option for heroin dependence, there is limited research focusing specifically on the treatment of prescription opioid dependence. In particular, the treatment of chronic pain in individuals with prescription opioid use disorders is underexplored.
CONCLUSIONS: While policy and educational initiatives appear to be effective in decreasing prescription opioid abuse and misuse, research focusing on the development and evaluation of treatments specific to prescription opioid dependence and its common comorbidities (e.g., chronic pain, depression) is critically needed.

Entities:  

Mesh:

Year:  2015        PMID: 26337039      PMCID: PMC4782928          DOI: 10.1176/appi.ajp.2015.15020262

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  43 in total

Review 1.  Contingency management for treatment of substance use disorders: a meta-analysis.

Authors:  Michael Prendergast; Deborah Podus; John Finney; Lisa Greenwell; John Roll
Journal:  Addiction       Date:  2006-11       Impact factor: 6.526

Review 2.  Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain.

Authors:  Teryl K Nuckols; Laura Anderson; Ioana Popescu; Allison L Diamant; Brian Doyle; Paul Di Capua; Roger Chou
Journal:  Ann Intern Med       Date:  2014-01-07       Impact factor: 25.391

3.  Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment.

Authors:  James Bell; Lieu Trinh; Bethany Butler; Deborah Randall; George Rubin
Journal:  Addiction       Date:  2009-07       Impact factor: 6.526

4.  Screening for substance abuse risk in cancer patients using the Opioid Risk Tool and urine drug screen.

Authors:  Joshua S Barclay; Justine E Owens; Leslie J Blackhall
Journal:  Support Care Cancer       Date:  2014-02-23       Impact factor: 3.603

5.  Gender and prescription opioids: findings from the National Survey on Drug Use and Health.

Authors:  Sudie E Back; Rebecca L Payne; Annie N Simpson; Kathleen T Brady
Journal:  Addict Behav       Date:  2010-06-22       Impact factor: 3.913

6.  Opioid pseudoaddiction--an iatrogenic syndrome.

Authors:  D E Weissman; J D Haddox
Journal:  Pain       Date:  1989-03       Impact factor: 6.961

7.  The multi-site prescription opioid addiction treatment study: 18-month outcomes.

Authors:  Jennifer Sharpe Potter; Jessica A Dreifuss; Elise N Marino; Scott E Provost; Dorian R Dodd; Lindsay S Rice; Garrett M Fitzmaurice; Margaret L Griffin; Roger D Weiss
Journal:  J Subst Abuse Treat       Date:  2014-08-02

8.  Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy.

Authors:  Stephen F Butler; Simon H Budman; Gilbert J Fanciullo; Robert N Jamison
Journal:  Clin J Pain       Date:  2010 Nov-Dec       Impact factor: 3.442

9.  Neonatal abstinence syndrome after methadone or buprenorphine exposure.

Authors:  Hendrée E Jones; Karol Kaltenbach; Sarah H Heil; Susan M Stine; Mara G Coyle; Amelia M Arria; Kevin E O'Grady; Peter Selby; Peter R Martin; Gabriele Fischer
Journal:  N Engl J Med       Date:  2010-12-09       Impact factor: 91.245

Review 10.  A systematic review of community opioid overdose prevention and naloxone distribution programs.

Authors:  Angela K Clark; Christine M Wilder; Erin L Winstanley
Journal:  J Addict Med       Date:  2014 May-Jun       Impact factor: 3.702

View more
  79 in total

Review 1.  Alcohol and Opioid Use, Co-Use, and Chronic Pain in the Context of the Opioid Epidemic: A Critical Review.

Authors:  Katie Witkiewitz; Kevin E Vowles
Journal:  Alcohol Clin Exp Res       Date:  2018-02-06       Impact factor: 3.455

2.  Negative Affect-Related Factors Have the Strongest Association with Prescription Opioid Misuse in a Cross-Sectional Cohort of Patients with Chronic Pain.

Authors:  Gadi Gilam; John A Sturgeon; Dokyoung S You; Ajay D Wasan; Beth D Darnall; Sean C Mackey
Journal:  Pain Med       Date:  2020-02-01       Impact factor: 3.750

3.  Cancer pain management in the emergency department: a multicenter prospective observational trial of the Comprehensive Oncologic Emergencies Research Network (CONCERN).

Authors:  Christopher J Coyne; Cielito C Reyes-Gibby; Danielle D Durham; Beau Abar; David Adler; Aveh Bastani; Steven L Bernstein; Christopher W Baugh; Jason J Bischof; Corita R Grudzen; Daniel J Henning; Matthew F Hudson; Adam Klotz; Gary H Lyman; Troy E Madsen; Daniel J Pallin; Juan Felipe Rico; Richard J Ryan; Nathan I Shapiro; Robert Swor; Charles R Thomas; Arvind Venkat; Jason Wilson; Sai-Ching Jim Yeung; Jeffrey M Caterino
Journal:  Support Care Cancer       Date:  2021-01-22       Impact factor: 3.603

Review 4.  Pharmacogenetics of Opioid Use Disorder Treatment.

Authors:  Richard C Crist; Toni-Kim Clarke; Wade H Berrettini
Journal:  CNS Drugs       Date:  2018-04       Impact factor: 5.749

5.  BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates.

Authors:  Norikazu Kiguchi; Huiping Ding; Gerta Cami-Kobeci; Devki D Sukhtankar; Paul W Czoty; Heather B DeLoid; Fang-Chi Hsu; Lawrence Toll; Stephen M Husbands; Mei-Chuan Ko
Journal:  Br J Anaesth       Date:  2019-03-01       Impact factor: 9.166

6.  A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates.

Authors:  Huiping Ding; Norikazu Kiguchi; Dennis Yasuda; Pankaj R Daga; Willma E Polgar; James J Lu; Paul W Czoty; Shiroh Kishioka; Nurulain T Zaveri; Mei-Chuan Ko
Journal:  Sci Transl Med       Date:  2018-08-29       Impact factor: 17.956

Review 7.  Corticolimbic circuitry in the modulation of chronic pain and substance abuse.

Authors:  Anna M W Taylor
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-05-10       Impact factor: 5.067

Review 8.  Using Screening Tests to Predict Aberrant Use of Opioids in Chronic Pain Patients: Caveat Emptor.

Authors:  Robert W Bailey; Kevin E Vowles
Journal:  J Pain       Date:  2017-06-29       Impact factor: 5.820

9.  A joint spatial model of opioid-associated deaths and treatment admissions in Ohio.

Authors:  David Kline; Staci Hepler; Andrea Bonny; Erin McKnight
Journal:  Ann Epidemiol       Date:  2019-03-12       Impact factor: 3.797

10.  Alcohol, marijuana, and opioid use disorders: 5-Year patterns and characteristics of emergency department encounters.

Authors:  Amber L Bahorik; Derek D Satre; Andrea H Kline-Simon; Constance M Weisner; Kelly C Young-Wolff; Cynthia I Campbell
Journal:  Subst Abus       Date:  2017-09-06       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.